Aerie Pharmaceuticals Prices Upsized Offering

Aerie Pharmaceuticals Prices Upsized Offering

Aerie Pharmaceuticals said it has priced its registered underwritten public offering of $75 million of shares at $53.75 per share. The offering was upsized by $25 million and is in addition to the $50 million of shares sold through an at-the-market program and expected to be issued around May 31. Proceeds will be used for general corporate purposes, including the expansion of its commercialization programs in North America for both […]

Read More ˃